SCHEMBL2275979

SCHEMBL2275979

CC=CC=CCCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.58
ALDH1A1 P00352 1/20 0.58
FASN P49327 1/20 0.55
FAAH O00519 4/20 0.50
TRPV1 Q8NER1 1/20 0.50
KDM4E B2RXH2 1/20 0.46
SOAT1 P35610 1/20 0.46
GMNN O75496 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
APEX1 P27695 1/20 0.43
CYP2C19 P33261 1/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30959011 1.00 TSHR (0.58) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL7981556 1.00 TSHR (0.58) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL2277625 1.00 TSHR (0.58) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL2275976 1.00 TSHR (0.58) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL2277623 1.00 TSHR (0.58) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL30635443 1.00 TSHR (0.58) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL30635438 1.00 TSHR (0.58) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL20610573 1.00 TSHR (0.58) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL21122035 1.00 TSHR (0.58) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL5319687 1.00 TSHR (0.58) TSHRALDH1A1FASNFAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115010737-A Method for collecting volatile components in microbial fermentation process and application 湖北省农业科学院中药材研究所 2022-09-06 CN claimed
EP-0980203-A4 ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES SQUIRES MERYL (US) 2004-05-06 EP claimed
EP-0980203-A1 ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES Squires, Meryl (US) 2000-02-23 EP claimed
US-5990163-A HYDROXY, EPOXY AND/OR CARBOXY DERIVATIVES OF METHOPRENE; ANTITUMOR,-CARCINOGENIC AND -PROLIFERATIVE AGENTS; SKIN DISORDERS THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1999-11-23 US claimed
EP-0620219-B1 Process for producing sulfolane compounds PHILLIPS PETROLEUM CO (US) 1998-11-11 EP claimed
WO-1998042188-A1 ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES SQUIRES MERYL (US) 1998-10-01 WO claimed
EP-0620219-A1 Process for producing sulfolane compounds PHILLIPS PETROLEUM COMPANY (US) 1994-10-19 EP claimed
US-5347018-A Freezing point depressants PHILLIPS PETROLEUM COMPANY (US) 1994-09-13 US claimed
US-5290953-A Sulfurization of conjugated diene; catalytic hydrogenation PHILLIPS PETROLEUM COMPANY (US) 1994-03-01 US claimed
US-20250241307-A1 AQUEOUS COMPOSITIONS COMPRISING SOLUBILZED LIPO-CHITOOLIGOSACCHARIDES Novonesis Plant Biosolutions A/S (DK) 2025-07-31 US disclosed
US-12232494-B2 Aqueous compositions comprising solubilzed lipo-chitooligosaccharides NOVOZYMES BIOAG A/S (DK) 2025-02-25 US disclosed
EP-4188088-A1 FORMULATIONS Syngenta Crop Protection AG (CH) 2023-06-07 EP disclosed
CN-115010737-B Method for collecting volatile components in microbial fermentation process and application 湖北省农业科学院中药材研究所 2023-01-10 CN disclosed
CN-115010737-A Method for collecting volatile components in microbial fermentation process and application 湖北省农业科学院中药材研究所 2022-09-06 CN disclosed
US-5347018-A Freezing point depressants PHILLIPS PETROLEUM COMPANY (US) 1994-09-13 US disclosed
US-5290953-A Sulfurization of conjugated diene; catalytic hydrogenation PHILLIPS PETROLEUM COMPANY (US) 1994-03-01 US disclosed
EP-0305913-B1 PROCESS FOR THE PRODUCTION OF DIEN-1-OLS, 9-HYDROXYDODEC-10-ENYL-1-TERT.BUTYL ETHER, AND ITS USE AS AN INTERMEDIATE IN THE SYNTHESIS OF 8,10-DODECANE DIENOL BASF Aktiengesellschaft (DE) 1991-05-22 EP disclosed
EP-0305913-A1 Process for the production of dien-1-ols, 9-hydroxydodec-10-enyl-1-tert.butyl ether, and its use as an intermediate in the synthesis of 8,10-dodecane dienol BASF Aktiengesellschaft (DE) 1989-03-08 EP disclosed
US-4570025-A HYDROGENATION IN THE PRESENCE OF PALLADIUM METAL ON AN ALUMINUM PHOSPHATE SUPPORT CATALYST PHILLIPS PETROLEUM COMPANY (US) 1986-02-11 US disclosed
US-4256903-A REACTING SULFUR DIOXIDE AND CONJUGATED DIENES IN THE PRESENCE OF A MONO OR DI-ALKENYL AMINE PHILLIPS PETROLEUM COMPANY (US) 1981-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250241307-A1 AQUEOUS COMPOSITIONS COMPRISING SOLUBILZED LIPO-CHITOOLIGOSACCHARIDES DDOST, STT3B, LCT TSHR 3902/4885ALDH1A1 4640/4885FASN 605/4885
US-12232494-B2 Aqueous compositions comprising solubilzed lipo-chitooligosaccharides DDOST, STT3B, LCT TSHR 3902/4885ALDH1A1 4640/4885FASN 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.